Effects of Gp96-Peptide Complex on Maturation of Dendritic Cells

杨威,曹春霞,吴胜利,刘青光,马清涌,潘承恩

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2005.08.015

2005-01-01

Abstract:Objective To investigate the relation of gp96-peptide complex to maturation of mouse marrow-derived dendritic cells (DCs). Methods Mouse bone marrow cells were cultured and stimulated with GM-CSF and IL-4 to obtain plenty of DCs. gp96-peptide complex obtained from H_22 liver cancer cells in mice were co-cultured with DCs in vitro. The contents of IL-12 and TNF-α in the supernatant and MHC-II antigen, CD40 and CD80 on DC membrane were determined by flow cytometry. Spleen lymphocytes of mice were activated by modified DCs and the cytotoxicity detected by 51Cr release method. Meanwhile, the alteration of proportions of CD8~+-IFNγ~+ and CD8~+-IL-10~+ cells, CD4~+- IFNγ~+ and CD4~+-IL-10~+ cells were analyzed. Results The DCs modified by gp96-peptide complex secreted large amount of IL-12, TNF-α and highly expressed MHC-II antigen, CD40, CD80 on the surface. Spleen lymphocytes of mice were activated and proportions of CD8~+- IFNγ~+ and CD4~+- IFNγ~+ were elevated. The activated and proliferated lymphocytes could specifically kill H_22 cells. Conclusions gp96-peptide complex can induce DC maturation to result in specific CTL response in vitro.